Human BCL2A1 Protein

<strong>Human BCL2A1 Protein</strong>_x000D_ <strong>Catalog number:</strong> B2011633_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 20.2 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> BCL2L5 protein, BCLA1-2 protein, GRS protein, BCLA1 2, HBPA1 protein, BCLA1-2, BFL1 protein, BCLA1 2 protein, BCL2A1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Li X, Dou J, You Q, Jiang Z. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy Eur J Med Chem. 2021 Aug 5;220:113539._x000D_ 2: Su W, Zhao Y, Wei Y, Zhang X, Ji J, Yang S. Exploring the Pathogenesis of Psoriasis Complicated With Atherosclerosis via Microarray Data Analysis Front Immunol. 2021 May 27;12:667690._x000D_ 3: Kim JT, Cho HJ, Cho MY, Lim J, Park ES, Lim JS, Lee HG. Prenylated Rab acceptor RABAC1 inhibits anti-apoptotic protein BCL2A1 and induces apoptosis Biochem Biophys Res Commun. 2019 Jun 11;513(4):940-946._x000D_ 4: Shaath H, Vishnubalaji R, Elkord E, Alajez NM. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19 Cells. 2020 Oct 29;9(11):2374._x000D_ 5: Zhang H, Nakauchi Y, Köhnke T, Stafford M, Bottomly D, Thomas R, Wilmot B, McWeeney SK, Majeti R, Tyner JW. Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia Nat Cancer. 2020 Aug;1(8):826-839._x000D_ 6: Vogler M. BCL2A1: the underdog in the BCL2 family Cell Death Differ. 2012 Jan;19(1):67-74._x000D_ 7: Joung J, Kirchgatterer PC, Singh A, Cho JH, Nety SP, Larson RC, Macrae RK, Deasy R, Tseng YY, Maus MV, Zhang F. CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity Nat Commun. 2022 Mar 25;13(1):1606._x000D_ 8: D de Araujo A, Lim J, Wu KC, Xiang Y, Good AC, Skerlj R, Fairlie DP. Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins J Med Chem. 2018 Apr 12;61(7):2962-2972._x000D_ 9: Tan X, Chen D, Guo S, Wang Y, Zou Y, Wu Z, Zhou F, Qin Z, Liu Z, Cao Y, Lin C, Yuan G, Yao K. Molecular stratification by BCL2A1 and AIM2 provides additional prognostic value in penile squamous cell carcinoma Theranostics. 2021 Jan 1;11(3):1364-1376._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/30042493">10: Lionnard L, Duc P, Brennan MS, Kueh AJ, Pal M, Guardia F, Mojsa B, Damiano MA, Mora S, Lassot I, Ravichandran R, Cochet C, Aouacheria A, Potts PR, Herold MJ, Desagher S, Kucharczak J. TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1 Cell Death Differ. 2019 May;26(5):902-917. </a>_x000D_ _x000D_ <strong>Products Related to Human BCL2A1 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>